Shanhu Qiu1,2, Xue Cai2, Zilin Sun3, Uwe Schumann1, Martina Zügel1, Jürgen Michael Steinacker1. 1. Division of Sports and Rehabilitation Medicine, Department of Medicine II, Ulm University, Ulm, Germany. 2. Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Medical School, Southeast University, Dingjiaqiao Str.87, Nanjing, 210009, China. 3. Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Medical School, Southeast University, Dingjiaqiao Str.87, Nanjing, 210009, China. zimuzhanglao@126.com.
Abstract
BACKGROUND: Irisin is a newly discovered hormone that is proposed to be a promising therapeutic target in obesity and type 2 diabetes. It has received remarkable attention recently, while inconsistent results have been shown regarding its association with chronic exercise training in adults. OBJECTIVE: The aim of this study was to evaluate the effects of chronic exercise training on circulating (plasma/serum) irisin in adults by meta-analyzing randomized controlled trials (RCTs) and non-randomized studies (NRSs) separately. METHODS: We conducted a search of the PubMed, Web of Science and Cochrane Library databases from January 2012 to September 2014 for studies published in English. Studies were included if they had an assessment of chronic (≥8 weeks) exercise training effects on circulating irisin in the general or clinical population (mean age ≥18 years) with reported outcomes of circulating irisin, and involved more than five participants. Pooled effect sizes (Cohen's d) with 95 % confidence intervals (CIs) for changes in circulating irisin were calculated by a random-effects model. Subgroup analyses were performed to evaluate the association between exercise modes and changes in circulating irisin. RESULTS: Of the 181 articles screened, 12 studies in eight articles were included, of which three were RCTs and nine were NRSs. In the three RCTs (a total of 173 healthy, untrained participants), chronic exercise training was associated with a moderate and significant overall effect in decreasing circulating irisin compared with the control (d = -0.46; 95 % CI -0.76 to -0.15). Chronic resistance exercise training showed a moderate and significant effect in decreasing circulating irisin compared with the control (d = -0.41; 95 % CI -0.75 to -0.06), while endurance exercise training only had a trend (d = -0.64; 95 % CI -1.32 to 0.04). In the nine NRSs (a total of 113 intervention participants), chronic exercise training was associated with a trivial and non-significant overall effect in decreasing circulating irisin compared with baseline (d = -0.04; 95 % CI -0.30 to 0.23). CONCLUSIONS: Chronic exercise training leads to significantly decreased circulating irisin levels in the RCTs, while evidence remains inconclusive in the NRSs. Well-designed RCTs that measure dietary intake and report changes of body fat percentage or insulin sensitivity/resistance index following chronic exercise training are required to confirm these findings.
BACKGROUND:Irisin is a newly discovered hormone that is proposed to be a promising therapeutic target in obesity and type 2 diabetes. It has received remarkable attention recently, while inconsistent results have been shown regarding its association with chronic exercise training in adults. OBJECTIVE: The aim of this study was to evaluate the effects of chronic exercise training on circulating (plasma/serum) irisin in adults by meta-analyzing randomized controlled trials (RCTs) and non-randomized studies (NRSs) separately. METHODS: We conducted a search of the PubMed, Web of Science and Cochrane Library databases from January 2012 to September 2014 for studies published in English. Studies were included if they had an assessment of chronic (≥8 weeks) exercise training effects on circulating irisin in the general or clinical population (mean age ≥18 years) with reported outcomes of circulating irisin, and involved more than five participants. Pooled effect sizes (Cohen's d) with 95 % confidence intervals (CIs) for changes in circulating irisin were calculated by a random-effects model. Subgroup analyses were performed to evaluate the association between exercise modes and changes in circulating irisin. RESULTS: Of the 181 articles screened, 12 studies in eight articles were included, of which three were RCTs and nine were NRSs. In the three RCTs (a total of 173 healthy, untrained participants), chronic exercise training was associated with a moderate and significant overall effect in decreasing circulating irisin compared with the control (d = -0.46; 95 % CI -0.76 to -0.15). Chronic resistance exercise training showed a moderate and significant effect in decreasing circulating irisin compared with the control (d = -0.41; 95 % CI -0.75 to -0.06), while endurance exercise training only had a trend (d = -0.64; 95 % CI -1.32 to 0.04). In the nine NRSs (a total of 113 intervention participants), chronic exercise training was associated with a trivial and non-significant overall effect in decreasing circulating irisin compared with baseline (d = -0.04; 95 % CI -0.30 to 0.23). CONCLUSIONS: Chronic exercise training leads to significantly decreased circulating irisin levels in the RCTs, while evidence remains inconclusive in the NRSs. Well-designed RCTs that measure dietary intake and report changes of body fat percentage or insulin sensitivity/resistance index following chronic exercise training are required to confirm these findings.
Authors: Fabian Sanchis-Gomar; Giuseppe Lippi; Sara Mayero; Carme Perez-Quilis; José L García-Giménez Journal: J Diabetes Date: 2012-09 Impact factor: 4.006
Authors: Friederike Scharhag-Rosenberger; Tim Meyer; Melissa Wegmann; Sandra Ruppenthal; Lars Kaestner; Arne Morsch; Anne Hecksteden Journal: Med Sci Sports Exerc Date: 2014-09 Impact factor: 5.411
Authors: S Ellefsen; O Vikmoen; G Slettaløkken; J E Whist; H Nygaard; I Hollan; I Rauk; G Vegge; T A Strand; T Raastad; B R Rønnestad Journal: Eur J Appl Physiol Date: 2014-06-07 Impact factor: 3.078
Authors: Rocio de la Iglesia; Patricia Lopez-Legarrea; Ana B Crujeiras; Maria Pardo; Felipe F Casanueva; Maria A Zulet; Jose A Martinez Journal: Clin Endocrinol (Oxf) Date: 2014-01-07 Impact factor: 3.478
Authors: Jian-Jun Liu; Melvin D S Wong; Wan Ching Toy; Clara S H Tan; Sylvia Liu; Xiao Wei Ng; Subramaniam Tavintharan; Chee Fang Sum; Su Chi Lim Journal: J Diabetes Complications Date: 2013-04-22 Impact factor: 2.852
Authors: Timea Kurdiova; Miroslav Balaz; Marek Vician; Denisa Maderova; Miroslav Vlcek; Ladislav Valkovic; Miroslav Srbecky; Richard Imrich; Olga Kyselovicova; Vitazoslav Belan; Ivan Jelok; Christian Wolfrum; Iwar Klimes; Martin Krssak; Erika Zemkova; Daniela Gasperikova; Jozef Ukropec; Barbara Ukropcova Journal: J Physiol Date: 2013-12-02 Impact factor: 5.182
Authors: Arturo Roca-Rivada; Cecilia Castelao; Lucía L Senin; María O Landrove; Javier Baltar; Ana Belén Crujeiras; Luisa María Seoane; Felipe F Casanueva; María Pardo Journal: PLoS One Date: 2013-04-11 Impact factor: 3.240
Authors: Paweł Jóźków; Dawid Koźlenia; Katarzyna Zawadzka; Marek Konefał; Paweł Chmura; Katarzyna Młynarska; Michał Kosowski; Marek Mędraś; Jan Chmura; Piotr Ponikowski; Jacek Daroszewski Journal: J Physiol Sci Date: 2018-05-14 Impact factor: 2.781
Authors: S Buscemi; D Corleo; S Vasto; C Buscemi; M F Massenti; D Nuzzo; G Lucisano; A M Barile; G Rosafio; V Maniaci; C Giordano Journal: Int J Obes (Lond) Date: 2017-10-13 Impact factor: 5.095
Authors: Adriana M Coletta; Nadia H Agha; Forrest L Baker; Grace M Niemiro; Preteesh L Mylabathula; Abenaa M Brewster; Therese B Bevers; Enrique Fuentes-Mattei; Karen Basen-Engquist; Susan C Gilchrist; Richard J Simpson Journal: Breast Cancer Res Treat Date: 2021-02-08 Impact factor: 4.872